IceCure Medical Ltd (ICCM)

Stock Price Forecast

The 1 analyst with a 12-month price forecast for IceCure Medical stock has a target of 2.5, which predicts a 146.31% increase from the current stock price of 1.02.

Price Target: $2.5 (+146.31%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.50	$2.50	$2.50	$2.50
Change	+146.31%	+146.31%	+146.31%	+146.31%

Analyst Ratings

According to 1 stock analyst, the rating for IceCure Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+146.31%	May 29, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+146.31%	Mar 28, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+146.31%	Nov 27, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+146.31%	Nov 8, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $2.5	Strong Buy	Reiterates	$2.5	+146.31%	Sep 12, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

6.04M

Increased by 83.41%

from 3.29M

Revenue Next Year

17.20M

Increased by 185.02%

from 6.04M

EPS This Year

-0.22

from -0.30

EPS Next Year

-0.17

from -0.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.87M	4.14M	3.09M	3.23M	3.29M	6.04M	17.20M	48.67M
Revenue Growth	132.76%	6.98%	-25.45%	4.67%	1.92%	83.41%	185.02%	182.89%
EPS	-0.22	-0.35	-0.46	-0.32	-0.30	-0.22	-0.17	0.07
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	14.22
No. Analysts	-	-	-	-	-	5	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	10.5M	29.0M	50.1M
Avg	6.0M	17.2M	48.7M
Low	3.7M	6.0M	46.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	217.9%	380.7%	191.2%
Avg	83.4%	185.0%	182.9%
Low	10.9%	-1.0%	171.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.18	-0.06	0.07
Avg	-0.22	-0.17	0.07
Low	-0.24	-0.24	0.07

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.